Insider Transactions in Q4 2024 at Sarepta Therapeutics, Inc. (SRPT)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 12
2024
|
Hans Lennart Rudolf Wigzell |
SELL
Open market or private sale
|
Direct |
10,500
-31.49%
|
$1,302,000
$124.84 P/Share
|
|
Dec 12
2024
|
Hans Lennart Rudolf Wigzell |
BUY
Exercise of conversion of derivative security
|
Direct |
10,500
+23.95%
|
$136,500
$13.71 P/Share
|
|
Dec 05
2024
|
Kathryn Jean Boor |
SELL
Open market or private sale
|
Direct |
1,636
-21.77%
|
$204,500
$125.55 P/Share
|
|
Nov 26
2024
|
Cristin Rothfuss EVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+12.64%
|
-
|
|
Nov 18
2024
|
Louise Rodino Klapac Head of R&D, CSO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,558
-6.31%
|
$464,916
$102.89 P/Share
|